Abstract
Biglycan is a matrix proteoglycan with a possible role in bone turnover. In a 4-week study with sham-operated or OVX biglycan-deficient or wildtype mice, we show that biglycan-deficient mice are resistant to OVX-induced trabecular bone loss and that there is a gender difference in the response to biglycan deficiency.
Original language | English |
---|---|
Journal | Journal of Bone and Mineral Research |
Volume | 18 |
Issue number | 12 |
Pages (from-to) | 2152-8 |
Number of pages | 7 |
ISSN | 0884-0431 |
DOIs | |
Publication status | Published - 2003 |
Keywords
- Animals
- Biglycan
- Bone Density
- Carrier Proteins
- Extracellular Matrix Proteins
- Female
- Glycoproteins
- Male
- Membrane Glycoproteins
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Models, Animal
- Osteoclasts
- Osteoporosis
- Osteoprotegerin
- Ovariectomy
- Proteoglycans
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
- Receptors, Cytoplasmic and Nuclear
- Receptors, Tumor Necrosis Factor